4basebio PLC (4BB.L) LSE

615.00

+0(+0.00%)

Updated at December 24 08:00AM

Currency In GBp

Valuation

Market Cap158.71M
Enterprise Value139.32M
P/E Ratio-6.61
PEG Ratio1.27
Price/Sales Ratio53.53
Price/Book Ratio5.02
Enterprise/Revenue47.53
Enterprise/EBITDA-5.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-8.1
Operating Margin-10.73

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.64

Income Statement

Revenue933,000
Revenue/Share0.11
Gross Profit630,000
EBITDA-10.97M
Net Income-12.33M
Diluted EPS-0.94

Balance Sheet

Total Cash26.11M
Total Cash/Share1.69
Total Debt15.44M
Total Debt/Equity0.81
Current Ratio11.36
Book Value Per Share1.23

Price History

52-Week Change-48.1
52-Week High1,300
52-Week Low605.36
Moving Average 50 Days724.75
Moving Average 200 Days928.94

Statistics

Average Volume1,087
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A